Table 2 Clinicopathological variables and the expression of TFAP2A-AS1
Parameters | N | TFAP2A-AS1 | ||
|---|---|---|---|---|
\(\overline{x}\) ± s | t | P-value | ||
Age/year | ||||
≤ 60 | 24 | 3.626 ± 2.637 | − 0.114 | 0.910 |
> 60 | 40 | 3.702 ± 2.557 | ||
Gender | ||||
Male | 40 | 3.894 ± 2.510 | 0.887 | 0.379 |
Female | 24 | 3.305 ± 2.670 | ||
Lymphatic metastasis | ||||
N0 | 21 | 2.531 ± 1.614 | − 2.599 | 0.012 |
N1–N2 | 43 | 4.231 ± 2.769 | ||
Organizational differentiation | ||||
Moderate and high | 36 | 3.312 ± 2.227 | − 1.500 | 0.139 |
Poorly | 28 | 4.245 ± 2.748 | ||
TNM stage | ||||
I | 5 | 1.927 ± 1.138 | 6.714 | 0.001 |
II | 11 | |||
III | 38 | 4.255 ± 2.652 | ||
IV | 10 | |||
Total | 64 | 3.673 ± 2.566 | 6.492 | 0.000 |